SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19 1, 2, 3,
4, 5. The dynamics of antibody-secreting plasmablasts and germinal centre B cells …

Background: Patients with chronic inflammatory disease (CID) treated with immunosuppressive
medications have increased risk for severe COVID-19. Although mRNA-based SARS-…

Long-lived bone marrow plasma cells (BMPCs) are a persistent and essential source of
protective antibodies 1, 2, 3, 4, 5, 6, 7. Individuals who have recovered from COVID-19 have a …

Germinal centres (GC) are lymphoid structures in which B cells acquire affinity-enhancing
somatic hypermutations (SHM), with surviving clones differentiating into memory B cells (MBCs…

SARS-CoV-2 mRNA vaccines induce robust anti-spike (S) antibody and CD4 + T cell
responses. It is not yet clear whether vaccine-induced follicular helper CD4 + T (T FH ) cell …

Influenza viruses remain a major public health threat. Seasonal influenza vaccination in
humans primarily stimulates pre-existing memory B cells, which differentiate into a transient …

Background: Individuals with chronic inflammatory diseases (CID) are frequently treated
with immunosuppressive medications that can increase their risk of severe COVID-19. While …

Abnormal levels of inflammation are associated with cardiovascular disease and mortality in
human immunodeficiency virus (HIV)–infected patients. Microbial translocation, which may …

Importance Immune dysregulation contributes to poorer outcomes in COVID-19. Objective
To investigate whether abatacept, cenicriviroc, or infliximab provides benefit when added to …

The primary two-dose SARS-CoV-2 mRNA vaccine series are strongly immunogenic in
humans, but the emergence of highly infectious variants necessitated additional doses and the …